Icecure Medical Ltd (ICCM)
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
Register of shareholders, changes and capital status – expiry of employee warrants
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice
Progressive Reports May 2026 Results
Progressive Announces Management Changes
Bond Awarded Government-Funded Contract in the U.S. Delivering More Than $3 Million In Annual Recurring Revenue
VolitionRx Announces Collaboration with Sysmex
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
ADMA INVESTOR DEADLINE: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
VolitionRx Announces Collaboration with Sysmex